Schedule 13G ownership disclosure

Immune Design Corp.

Security class unavailable · CUSIP: 45252L103

Event date: 2015-04-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,161,465
Percent of class
10.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932440-15-000144
Form type
SC 13G
Filer
IMMUNE DESIGN CORP.
CIK
CIK 1437786
Filed
Apr 28, 2015
Reporting period
Apr 23, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub